Publications by authors named "O B Trifonova"

: The incidence of many diseases increases with age and leads to multimorbidity, characterized by the presence of multiple diseases in old age. This phenomenon is closely related to systemic metabolic changes; the most suitable way to study it is through metabolomics. The use of accumulated metabolomic data to characterize this phenomenon at the system level may provide additional insight into the nature and strength of aging-disease relationships.

View Article and Find Full Text PDF

Using analytical technologies it is possible now to measure the entire diversity of molecules even in a small amount of biological samples. Metabolomic technologies simultaneously analyze thousands of low-molecular substances in a single drop of blood. Such analytical performance opens new possibilities for clinical laboratory diagnostics, still relying on the measurement of only a limited number of clinically significant substances.

View Article and Find Full Text PDF

In terms of time, cost, and reproducibility of clinical laboratory tests, a mass spectrometric clinical blood metabogram (CBM) enables the investigation of the blood metabolome. Metabogram's components provide clinically relevant information by describing related groups of blood metabolites connected to humoral regulation, the metabolism of lipids, carbohydrates and amines, lipid intake into the organism, and liver function. For further development of the CBM approach, the ability of CBM to detect metabolic changes in the blood in the early stages of Parkinson's disease (PD) was studied in this work.

View Article and Find Full Text PDF
Article Synopsis
  • The clinical blood metabogram (CBM) is a tailored blood test designed to analyze metabolite groups while being efficient in time, cost, and reproducibility for clinical settings.
  • The study evaluated the CBM in 18 healthy individuals, 12 prediabetics, and 64 type 2 diabetes patients, identifying significant metabolic changes related to diabetes, such as alterations in carbohydrates, ketone bodies, and amino acids.
  • The CBM proved effective in distinguishing metabolic differences among diabetic patients, offering valuable insights for diagnosing and managing diabetes.
View Article and Find Full Text PDF

Recently, a clinical blood metabogram was developed as a fast, low-cost and reproducible test that allows the implementation of metabolomics in clinical practice. The components of the metabogram are functionally related groups of blood metabolites associated with humoral regulation, the metabolism of lipids, carbohydrates and amines, lipid intake into the organism, and liver function, thereby providing clinically relevant information. It is known that the gut microbiota affects the blood metabolome, and the components of the blood metabolome may affect the composition of the gut microbiota.

View Article and Find Full Text PDF